VESICARE

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VESICARE contains one active pharmaceutical ingredient (API):

1 Solifenacin UNII KKA5DLD701 - SOLIFENACIN SUCCINATE

Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor. Read about Solifenacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VESICARE Oral suspension	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BD08	Solifenacin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 540300202114215, 540300204117211, 540300208112214, 540300210117211
Country: CA	Health Products and Food Branch	Identifier(s): 02277263, 02277271
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 16956775, 16956781
Country: EE	Ravimiamet	Identifier(s): 1162415, 1162426, 1162437, 1162448, 1162459, 1162460, 1162471, 1162482, 1162493, 1162505, 1162516, 1162527, 1162538, 1162549, 1162550, 1162561, 1178333, 1178344, 1442720, 1442731, 1668168
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 34009936551671, 34081, 365516, 66257, 66258, 66671854, 80116, RVG29152
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 018594, 018677, 018685, 018694, 087572
Country: FR	Base de données publique des médicaments	Identifier(s): 60608174, 66671854, 67862887
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 198761, 198763, 358489, 368096, 368098, 369029, 373743, 373805, 377086, 377088, 379986, 379987, 80453, 80456
Country: HK	Department of Health Drug Office	Identifier(s): 54340, 54341
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6000, 6001
Country: JP	医薬品医療機器総合機構	Identifier(s): 2590011F1028, 2590011F2024, 2590011F3020, 2590011F4027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1017425, 1017426, 1017427, 1017428, 1017429, 1017430, 1017431, 1017432, 1017433, 1017434, 1017435, 1017436, 1017437, 1017438, 1017439, 1017440, 1022602, 1022603, 1053691, 1053692, 1074815
Country: MT	Medicines Authority	Identifier(s): MA1387/00301, MA1387/00302, MA1387/00303, PI908/18801A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 628M2005
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 167215, 75337, 75345
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11982, 11983
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100134878, 100134890, 100330332
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W43104001, W43105001, W62488001
Country: SG	Health Sciences Authority	Identifier(s): 13702P, 13703P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 4453021, 4453022
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699043890369, 8699043890376, 8699043890383, 8699043890390
Country: US	FDA, National Drug Code	Identifier(s): 51248-150, 51248-151, 51248-250, 55154-3877, 55154-3878, 70518-1866
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/5.4/0490, A39/5.4/0491